HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Bentz Selected Research

Etoposide (VP 16)

3/2008Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
3/2008Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Bentz Research Topics

Disease

5Neoplasms (Cancer)
01/2003 - 03/2000
4Lymphoma (Lymphomas)
03/2008 - 04/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2017
2Infections
01/2017 - 03/2008
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2012
1Leukopenia
03/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2008
1Thrombocytopenia (Thrombopenia)
03/2008
1Acute Kidney Injury (Acute Renal Failure)
02/2003
1Hemolytic-Uremic Syndrome
02/2003
1Thrombosis (Thrombus)
02/2003
1Breast Neoplasms (Breast Cancer)
07/2001
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2001
1Neoplasm Metastasis (Metastasis)
02/2001
1Leukemia
10/2000
1Body Weight (Weight, Body)
09/2000
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
08/2000
1Disease Progression
04/2000
1Meningitis
02/2000

Drug/Important Bio-Agent (IBA)

3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2023 - 01/2017
2Rituximab (Mabthera)FDA Link
10/2012 - 03/2008
2Etoposide (VP 16)FDA LinkGeneric
03/2008 - 03/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2008 - 03/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 03/2008
2DNA (Deoxyribonucleic Acid)IBA
06/2003 - 10/2000
2ParaffinIBA
07/2001 - 02/2001
2DNA ProbesIBA
04/2001 - 03/2000
2Proteins (Proteins, Gene)FDA Link
09/2000 - 08/2000
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2023
1fludarabineIBA
12/2017
1Imatinib Mesylate (Gleevec)FDA Link
11/2017
1InterferonsIBA
11/2017
1pegfilgrastim (Neulasta)FDA Link
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017
1Prednisone (Sone)FDA LinkGeneric
03/2008
1Vincristine (Oncovin)FDA LinkGeneric
03/2008
1Shiga Toxins (Vero Toxin)IBA
02/2003
1Shiga Toxin (Shigella Toxin)IBA
02/2003
1Complementary DNA (cDNA)IBA
01/2003
1Estrogen ReceptorsIBA
07/2001
1XenobioticsIBA
09/2000
1DioxinsIBA
09/2000
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
09/2000
1NF-kappa B (NF-kB)IBA
08/2000
1Granzymes (Granzyme)IBA
04/2000
1Antineoplastic Agents (Antineoplastics)IBA
04/2000
1PerforinIBA
04/2000
1AntigensIBA
04/2000
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
02/2000

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2023 - 03/2008
2Therapeutics
01/2017 - 03/2008
1Platelet Transfusion (Blood Platelet Transfusions)
01/2017
1Combination Drug Therapy (Combination Chemotherapy)
03/2008
1Mohs Surgery (Mohs' Micrographic Surgery)
02/2001
1Aftercare (After-Treatment)
02/2001